Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study - Lipton, Richard B.; Serrano, Daniel; Nicholson, Robert A.; Buse, Dawn C.; Runken, M. Chris; Reed, Michael L. (Headache, 2013)
Keywords: acute treatment; Adult; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Chronic Disease; chronic migraine; Data processing; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Headaches; Humans; Longitudinal Studies; Male; Middle Aged; migraine; Migraine Disorders - chemically induced; Migraine Disorders - drug therapy; Migraine Disorders - epidemiology; migraine progression; nonsteroidal anti-inflammatory drug; Nonsteroidal anti-inflammatory drugs; Piperidines - adverse effects; Piperidines - therapeutic use; Population Surveillance - methods; Prevalence; Quality of life; Serotonin 5-HT1 Receptor Agonists - adverse effects; Serotonin 5-HT1 Receptor Agonists - therapeutic use; Sumatriptan - adverse effects; Sumatriptan - therapeutic use; triptan; Tryptamines - adverse effects; Tryptamines - therapeutic use; United States - epidemiology; migraine progression; migraine; triptan; chronic migraine; acute treatment; nonsteroidal anti-inflammatory drug